.png
)
69th DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs Minutes of the 69th Drugs Consultative Committee (DCC) meeting held on 24.06.2026 — Agenda Nos. 2 & 3 Meeting: 69th DCC, held on 24.06.2026 Agenda 2: Comprehensive Regulatory…
69th DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses Vaayath Regulatory Desk | Drugs Consultative Committee, 69th Meeting | Held on 24.06.2026 The Drugs Consultative Committee (DCC), at its 69th meeting held on 24.06.2026, took up an…
4th June, 2026 Drugs Controller General of India (DCGI), issued a formal circular directing all drug manufacturers and all stakeholders to ensure they have a working pharmacovigilance (PV) system in place — one that is fully compliant with the Drugs…
January 6, 2023 Government of India vide gazette notification no. GSR 922 (E) dated 28.12.2023 has notified new set of rules and regulations for implementation of Good Manufacturing Practices for manufacturing of pharmaceutical products. The new rules are covered under…